Skip to main content

Advertisement

Log in

Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

This study aims to determine the clinical features and seasonal patterns associated with shigellosis, the antimicrobial resistance frequencies of the isolates obtained during the period 2006–2012 for 22 antibiotics, and the molecular characterization of multidrug-resistant strains isolated from endemic cases of shigellosis in the remote islands of India, with special reference to fluoroquinolone and third-generation cephalosporins resistance. During the period from January 2006 to December 2011, stool samples were obtained and processed to isolate Shigella spp. The isolates were evaluated with respect to their antibiotic resistance pattern and various multidrug resistance determinants, including resistance genes, quinolone resistance determinants, and extended-spectrum β-lactamase (ESBL) production. Morbidity for shigellosis was found to be 9.3 % among children in these islands. Cases of shigellosis occurred mainly during the rainy seasons and were found to be higher in the age group 2–5 years. A wide spectrum of resistance was observed among the Shigella strains, and more than 50 % of the isolates were multidrug-resistant. The development of multidrug-resistant strains was found to be associated with various drug-resistant genes, multiple mutations in the quinolone resistance-determining region (QRDR), and the presence of plasmid-mediated quinolone-resistant determinants and efflux pump mediators. This report represents the first presentation of the results of long-term surveillance and molecular characterization concerning antimicrobial resistances in clinical Shigella strains in these islands. Information gathered as part of the investigations will be instrumental in identifying emerging antimicrobial resistance, for developing treatment guidelines appropriate for that community, and to provide baseline data with which to compare outbreak strains in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ahmed AM, Furuta K, Shimomura K, Kasama Y, Shimamoto T (2006) Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol 55:1685–1691

    Article  CAS  PubMed  Google Scholar 

  2. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651–666

    CAS  PubMed Central  PubMed  Google Scholar 

  3. World Health Organization (WHO) (2005) Shigellosis: disease burden, epidemiology and case management. Wkly Epidemiol Rec 80:94–99

    Google Scholar 

  4. Christopher PR, David KV, John SM, Sankarapandian V (2009) Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev (4):CD006784

  5. Ashkenazi S, Levy I, Kazaronovski V, Samra Z (2003) Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51:427–429

    Article  CAS  PubMed  Google Scholar 

  6. Bennish ML, Salam MA (1992) Rethinking options for the treatment of shigellosis. J Antimicrob Chemother 30:243–247

    Article  CAS  PubMed  Google Scholar 

  7. Zafar A, Hasan R, Nizami SQ, von Seidlein L, Soofi S, Ahsan T, Chandio S, Habib A, Bhutto N, Siddiqui FJ, Rizvi A, Clemens JD, Bhutta ZA (2009) Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan. Int J Infect Dis 13:668–672

    Article  PubMed  Google Scholar 

  8. Ghosh AR, Sehgal SC (1996) Existing status of shigellosis in Andaman & Nicobar Islands. Indian J Med Res 103:134–137

    CAS  PubMed  Google Scholar 

  9. Roy S, Thanasekaran K, Dutta Roy AR, Sehgal SC (2006) Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Trop Med Int Health 11:1694–1698

    Article  CAS  PubMed  Google Scholar 

  10. Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sayi DS, Thanasekaran K, Manimunda SP, Ghosh AR, Bharadwaj AP, Singhania M, Roy S (2012) Antimicrobial resistance in Shigella—rapid increase & widening of spectrum in Andaman Islands, India. Indian J Med Res 135:365–370

    CAS  PubMed  Google Scholar 

  11. World Health Organization (WHO) (1987) Manual for laboratory investigation of acute enteric infections. CDD/83.3. WHO, Geneva, Switzerland

    Google Scholar 

  12. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. M100–S22. CLSI, Wayne, PA

    Google Scholar 

  13. Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sudharama SD, Manimunda SP, Bharadwaj AP, Singhania M, Roy S (2011) Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India. Microb Drug Resist 17:329–332

    Article  PubMed  Google Scholar 

  14. Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T (2008) Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol 57:856–863

    Article  CAS  PubMed  Google Scholar 

  15. Talukder KA, Mondol AS, Islam MA, Islam Z, Dutta DK, Khajanchi BK, Azmi IJ, Hossain MA, Rahman M, Cheasty T, Cravioto A, Nair GB, Sack DA (2007) A novel serovar of Shigella dysenteriae from patients with diarrhoea in Bangladesh. J Med Microbiol 56:654–658

    Article  CAS  PubMed  Google Scholar 

  16. Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S (2005) Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 49:1660–1661

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53:639–645

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Fullá N, Prado V, Durán C, Lagos R, Levine MM (2005) Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg 72:851–854

    PubMed  Google Scholar 

  19. von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J (2006) A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3(9):e353

    Article  Google Scholar 

  20. Zhang W, Luo Y, Li J, Lin L, Ma Y, Hu C, Jin S, Ran L, Cui S (2011) Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother 66:2527–2535

    Article  CAS  PubMed  Google Scholar 

  21. World Health Organization (WHO) (2005) Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. WHO, Geneva, Switzerland. Available online at: http://whqlibdoc.who.int/publications/2005/9241592330.pdf. Accessed 22nd Sep 2012

  22. Niyogi SK (2007) Increasing antimicrobial resistance—an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 13:1141–1143

    Article  CAS  PubMed  Google Scholar 

  23. Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y (1998) Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991–1995. APMIS 106:879–883

    Article  CAS  PubMed  Google Scholar 

  24. Egah DZ, Banwat EB, Audu ES, Allanana JA, Danung ML, Damen JG, Badung BP (2003) Multiple drug resistant strains of Shigella isolated in Jos, central Nigeria. Niger Postgrad Med J 10:154–156

    CAS  PubMed  Google Scholar 

  25. Lee JC, Oh JY, Kim KS, Jeong YW, Cho JW, Park JC, Seol SY, Cho DT (2001) Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 109:228–234

    Article  CAS  PubMed  Google Scholar 

  26. Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z (1995) Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 39:819–823

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Fortineau N, Naas T, Gaillot O, Nordmann P (2001) SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate. J Antimicrob Chemother 47:685–688

    Article  CAS  PubMed  Google Scholar 

  28. Fasano A, Noriega FR, Liao FM, Wang W, Levine MM (1997) Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40:505–511

    CAS  PubMed  Google Scholar 

  29. Niyogi SK, Vargas M, Vila J (2004) Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clin Microbiol Infect 10:574–576

    Article  CAS  PubMed  Google Scholar 

  30. Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C (2002) Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 46(10):3156–3163

    Article  PubMed Central  PubMed  Google Scholar 

  31. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC (2005) Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol 43:2608–2612

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Martínez-Salazar JM, Alvarez G, Gómez-Eichelmann MC (1986) Frequency of four classes of tetracycline resistance determinants in Salmonella and Shigella spp. clinical isolates. Antimicrob Agents Chemother 30:630–631

    Article  PubMed Central  PubMed  Google Scholar 

  33. Peirano G, Agersø Y, Aarestrup FM, dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301–305

    Article  CAS  PubMed  Google Scholar 

  34. Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232–260

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6):1037–1050

    Article  CAS  PubMed  Google Scholar 

  36. Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, Torres C (2004) Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 48(10):3996–4001

    Article  PubMed Central  PubMed  Google Scholar 

  37. Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC (2010) Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents 35:76–79

    Article  CAS  PubMed  Google Scholar 

  38. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S (2009) Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 47:1379–1385

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109–1117

    Article  CAS  PubMed  Google Scholar 

  40. Talukder KA, Khajanchi BK, Islam MA, Dutta DK, Islam Z, Safa A, Khan GY, Alam K, Hossain MA, Malla S, Niyogi SK, Rahman M, Watanabe H, Nair GB, Sack DA (2004) Genetic relatedness of ciprofloxacin resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother 54:730–734

    Article  CAS  PubMed  Google Scholar 

  41. Gad GFM, Abd El-Ghafar F, El-Domany RAA, Hashem ZS (2010) Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases. Braz J Microbiol 41:333–344

    Article  CAS  PubMed  Google Scholar 

  42. Falsafi T, Ehsani A, Niknam V (2009) The role of active efflux in antibiotic-resistance of clinical isolates of Helicobacter pylori. Indian J Med Microbiol 27(4):335–340

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are thankful to the Indian Council of Medical Research for providing financial grants for the study; to the Director of the institute, Dr. P. Vijayachari, for the administrative support; to the Directorate of Health Services (Andaman & Nicobar Islands) and INHS Dhanwantari for their extensive support and help during the work; and to the other support staff, Mr. S.R. Ghosal, Mr. S. Minj, and Mr. Nathaniel Martin.

Ethics approval

The study was cleared by the institutional ethical committee.

Funding

The study was supported by grants from the Indian Council of Medical Research (vide letter no. Tribal-26/2006/ECD-II). The project was terminated in August 2010.

Transparency declaration

None to declare.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Roy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhattacharya, D., Bhattacharya, H., Thamizhmani, R. et al. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis 33, 157–170 (2014). https://doi.org/10.1007/s10096-013-1937-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-013-1937-2

Keywords

Navigation